Cargando…

Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA)

BACKGROUND: We aimed to establish an immune-related gene (IRG) based signature that could provide guidance for clinical bladder cancer (BC) prognostic surveillance. METHODS: Differentially expressed IRGs and transcription factors (TFs) between BCs and normal tissues were extracted from transcriptome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Qianwei, Liu, Shouyong, Jiang, Silin, Li, Tao, Wang, Zengjun, Wang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658175/ https://www.ncbi.nlm.nih.gov/pubmed/33209669 http://dx.doi.org/10.21037/tau-20-696

Ejemplares similares

Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder
por: Santoni, Matteo, et al.
Publicado: (2012)

The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA)
por: Xie, Ruiyan, et al.
Publicado: (2022)

Small nucleolar RNAs signature (SNORS) identified clinical outcome and prognosis of bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Identification of autophagy‐related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2021)

Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
por: Wang, Yi, et al.
Publicado: (2021)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer
por: Wang, Zhiyong, et al.
Publicado: (2018)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

A Multiomics Profiling Based on Online Database Revealed Prognostic Biomarkers of BLCA
por: Li, Hanwen, et al.
Publicado: (2022)

Identification of small molecule drugs and development of a novel autophagy‐related prognostic signature for kidney renal clear cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2020)

An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression
por: Zou, Zhenhai, et al.
Publicado: (2023)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2020)

Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma
por: Jiang, Silin, et al.
Publicado: (2021)

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings
por: Zhu, Shusheng, et al.
Publicado: (2023)

Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies
por: Cai, Qiliang, et al.
Publicado: (2015)

RNA m5C methylation orchestrates BLCA progression via macrophage reprogramming
por: Yan, Dali, et al.
Publicado: (2023)

HYAL3 as a potential novel marker of BLCA patient prognosis
por: Liu, Jun-peng, et al.
Publicado: (2022)

The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma
por: Cheng, Huan, et al.
Publicado: (2012)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration
por: Xing, Qianwei, et al.
Publicado: (2022)

A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2021)

CD10 expression in urothelial carcinoma of the bladder
por: Bahadir, Burak, et al.
Publicado: (2009)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma
por: Xu, Chaojie, et al.
Publicado: (2022)

Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer
por: Zhang, Jiange, et al.
Publicado: (2022)

The role of cell adhesion molecules in the progression of bladder urothelial carcinomas
por: Săndulescu, Andrei Ştefan, et al.
Publicado: (2022)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Independent prognostic miRNAs for bladder urothelial carcinoma
por: Hu, Yingbo, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

Angiogenesis related gene expression significantly associated with the prognostic role of an urothelial bladder carcinoma
por: Wang, Jianfeng, et al.
Publicado: (2020)

Overexpressed pseudogene MT1L associated with tumor immune infiltrates and indicates a worse prognosis in BLCA
por: Ding, Yanpeng, et al.
Publicado: (2021)

Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics
por: Wang, Dongjiao, et al.
Publicado: (2022)

Metastasectomy could not improve the survival of metastatic urothelial carcinoma: evidence from a meta-analysis
por: Xing, Qianwei, et al.
Publicado: (2020)

Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder
por: Kucuk, Ulku, et al.
Publicado: (2015)

Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer
por: Yang, Guoliang, et al.
Publicado: (2020)

Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms
por: Wang, Yi, et al.
Publicado: (2022)

Small bowel obstruction secondary to metastatic urothelial bladder cancer
por: Wasfie, Tarik, et al.
Publicado: (2023)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine
por: Sun, Zhuolun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tug014pnhuec34snj8ahii8tqk